| 100686-5 | JC virus DNA (viral load) (CSF, naa with probe detection) |
| 100690-7 | Toxoplasma gondii DNA (CSF, naa with probe detection) |
| 100692-3 | Varicella zoster virus DNA (viral load) (CSF, naa with probe detection) |
| 100756-6 | Oligoclonal bands (CSF, isoelectric focusing) |
| 100841-6 | Zinc finger protein of the cerebellum 4 Ab (CSF, qualitative, line blot) |
| 100980-2 | BK virus DNA (viral load) (CSF, naa with probe detection) |
| 100987-7 | Lymphocyte T-cell and B-cell and Natural killer subsets panel - Cerebral spinal fluid |
| 100996-8 | Neurofilament light chain (CSF) |
| 101227-7 | Recoverin Ab (CSF, qualitative, immunoblot) |
| 101228-5 | PCA-Tr Ab (CSF, qualitative, immunoblot) |
| 101230-1 | Zinc finger protein of the cerebellum 4 Ab (CSF, qualitative, immunoblot) |
| 101231-9 | Neuronal nuclear Ab (CSF, qualitative, immunoblot) |
| 101232-7 | Glutamate decarboxylase 65 Ab (CSF, qualitative, immunoblot) |
| 101234-3 | Glial nuclear type 1 Ab (CSF, qualitative, immunoblot) |
| 101236-8 | Titin Ab (CSF, qualitative, immunoblot) |
| 101241-8 | Contactin-associated protein 2 Ab (CSF, qualitative, immunofluorescence) |
| 101242-6 | Dipeptidyl aminopeptidase-like protein 6 Ab (CSF, qualitative, immunofluorescence) |
| 101244-2 | Leucine-rich glioma-inactivated protein 1 Ab (CSF, qualitative, immunofluorescence) |
| 101247-5 | NMDAR Ab (CSF, qualitative, immunofluorescence) |
| 101416-6 | Pediatric autoimmune central nervous system disorders evaluation panel - Cerebral spinal fluid |
| 101449-7 | Neurochondrin Ab (CSF, qualitative, cell binding immunofluorescent assay) |
| 101451-3 | Neurochondrin Ab (CSF, qualitative, immunofluorescence) |
| 101453-9 | Neurochondrin Ab (CSF, immunofluorescence) |
| 101457-0 | Septin-7 IgG Ab (CSF, immunofluorescence) |
| 101459-6 | Septin-5 IgG Ab (CSF, immunofluorescence) |
| 101461-2 | Septin-5 IgG Ab (CSF, qualitative, immunofluorescence) |
| 101462-0 | Septin-5 IgG Ab (CSF, qualitative, cell binding immunofluorescent assay) |
| 101464-6 | Septin-7 IgG Ab (CSF, qualitative, immunofluorescence) |
| 101466-1 | Septin-7 IgG Ab (CSF, qualitative, cell binding immunofluorescent assay) |
| 101648-4 | 14-3-3 Ag (CSF, immunoassay) |
| 101649-2 | Tau protein (CSF, immunoassay) |
| 101650-0 | Prion disease risk (CSF, immunoassay narrative) |
| 101662-5 | Abnormal Prion Protein (CSF, qualitative, rt-quic) |
| 101732-6 | JC virus DNA (viral load) (CSF, naa with probe detection) |
| 101752-4 | Tau protein/Tau protein.phosphorilated 181 (CSF) |
| 101814-2 | BK virus DNA (viral load) (CSF, naa with probe detection) |
| 101815-9 | Cytomegalovirus DNA (viral load) (CSF, naa with probe detection) |
| 101817-5 | Epstein Barr virus DNA (viral load) (CSF, naa with probe detection) |
| 101818-3 | Herpes virus 6 DNA (CSF, naa with probe detection) |
| 101867-0 | Ma2 Antibody (CSF, qualitative, immunoassay) |
| 101870-4 | GABAAR IgG Ab (CSF, cell binding immunofluorescent assay) |
| 101871-2 | IgLON5 IgG Ab (CSF, cell binding immunofluorescent assay) |
| 101872-0 | Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab (CSF, cell binding immunofluorescent assay) |
| 101873-8 | Metabotropic glutamate receptor 1 IgG Ab (CSF, cell binding immunofluorescent assay) |
| 102036-1 | Abnormal Prion Protein Document (CSF, rt-quic) |
| 10328-3 | Lymphocytes/Leukocytes (CSF, manual count) |
| 10329-1 | Monocytes/Leukocytes (CSF, manual count) |
| 10333-3 | Appearance (CSF) |
| 10335-8 | Color (CSF) |
| 103566-6 | Metagenomic DNA and RNA Sequencing |
| 103686-2 | Pneumocystis jirovecii DNA (CSF, qualitative, naa with probe detection) |
| 103687-0 | Coccidioides sp DNA (CSF, qualitative, naa with probe detection) |
| 103688-8 | Blastomyces sp DNA (CSF, qualitative, naa with probe detection) |
| 103689-6 | Histoplasma sp DNA (CSF, qualitative, naa with probe detection) |
| 103690-4 | Fungal pathogens panel - Cerebral spinal fluid (naa with probe detection) |
| 103715-9 | GABAAR IgG Ab (CSF, qualitative, cell binding immunofluorescent assay) |
| 103961-9 | Borrelia burgdorferi.VlsE1+pepC10 Ab (CSF, immunoassay) |
| 104134-2 | Dementia evaluation panel - Cerebral spinal fluid |
| 104264-7 | Galactosylceramidase (CSF, lc/ms/ms) |
| 104340-5 | Borna disease virus RNA (CSF, qualitative, naa with probe detection) |
| 104347-0 | Borrelia recurrentis (CSF, qualitative, organism specific culture) |
| 104354-6 | Borrelia recurrentis DNA (CSF, qualitative, naa with probe detection) |
| 104355-3 | Borrelia recurrentis DNA (CSF, qualitative, sequencing) |
| 104397-5 | European tick borne encephalitis virus IgM Ab (CSF, immunoassay) |
| 104399-1 | European tick borne encephalitis virus RNA (CSF, qualitative, naa with probe detection) |
| 104457-7 | Varicella zoster virus IgA Ab (CSF, qualitative, immunoassay) |
| 104459-3 | Varicella zoster virus IgG Ab (CSF, qualitative, immunoassay) |
| 105522-7 | Phosphodiesterase 10A IgG Ab (CSF, immunofluorescence) |
| 105524-3 | Tripartite motif containing 46 IgG Ab (CSF, qualitative, immunofluorescence) |
| 105526-8 | Tripartite motif containing 46 IgG Ab (CSF, immunofluorescence) |
| 106057-3 | Beta-Amyloid 1-42 and 1-40 panel - Cerebral spinal fluid |
| 106507-7 | California encephalitis virus IgG and IgM Qualitative (CSF, qualitative, immunofluorescence) |
| 10680-7 | Herpes simplex virus identified (CSF, electron microscopy) |
| 106942-6 | CV2 IgG Ab (CSF, qualitative, line blot) |
| 107013-5 | Mycobacterium preliminary growth (CSF, qualitative, organism specific culture) |
| 107194-3 | Ma+Ta Ab (CSF, qualitative, line blot) |
| 107345-1 | Herpes virus 7 DNA (CSF, qualitative, naa with probe detection) |
| 10736-7 | Virus identified (CSF, electron microscopy) |
| 107481-4 | Chemokine (C-X3-C motif) ligand 1 (CSF) |
| 107598-5 | Microscopic observation (CSF, acid fast stain.kinyoun modified) |
| 108092-8 | Rickettsia sp DNA (CSF, qualitative, naa with probe detection) |
| 108093-6 | Usutu virus RNA (CSF, qualitative, naa with probe detection) |
| 108156-1 | Meningitis+Encephalitis pathogens (CSF, naa with non-probe detection) |
| 108157-9 | Meningitis+Encephalitis pathogens (CSF, qualitative, naa with non-probe detection) |
| 108210-6 | Galactomannan Ag (CSF, qualitative, immunoassay) |
| 108214-8 | Epstein Barr virus DNA (viral load) (CSF, naa with probe detection) |
| 108215-5 | Epstein Barr virus DNA (viral load) (CSF, naa with probe detection) |
| 108220-5 | Cytomegalovirus DNA (viral load) (CSF, naa with probe detection) |
| 108221-3 | Cytomegalovirus DNA (viral load) (CSF, naa with probe detection) |
| 10897-7 | Eastern equine encephalitis virus IgG Ab (CSF, immunofluorescence) |
| 10899-3 | Eastern equine encephalitis virus IgM Ab (CSF, immunofluorescence) |
| 109424-2 | Bilirubin.total (CSF) |
| 109425-9 | Beta-2-Microglobulin (CSF) |
| 109426-7 | Aspergillus flavus Ab (CSF) |
| 109427-5 | Acanthamoeba sp Ab (CSF) |
| 109428-3 | 5-Methyltetrahydrofolate (CSF) |
| 109431-7 | Adenovirus DNA (CSF) |
| 109432-5 | AMPAR2 IgG Ab (CSF) |
| 109447-3 | Borrelia burgdorferi IgA Ab (CSF) |
| 109448-1 | Blastomyces dermatitidis IgG Ab (CSF) |